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Background: Chronic diseases are posing an increasing challenge to society, with the associated burden falling
disproportionally on more deprived individuals and geographical areas. Although the existence of a socioeconomic
health gradient is one of the main concerns of health policy across the world, health information systems
commonly do not have reliable data to detect and monitor health inequalities and inequities. The objectives of this
study were to measure the level of socioeconomic-related inequality in prevalence of chronic diseases and to
investigate the extent and direction of inequities in health care provision.
Methods: A dataset linking clinical and administrative information of the entire population living in the Basque
Country, Spain (over 2 million individuals) was used to measure the prevalence of 52 chronic conditions and to
quantify individual health care costs. We used a concentration-index approach to measure the extent and direction
of inequality with respect to the deprivation of the area of residence of each individual.
Results: Most chronic diseases were found to be disproportionally concentrated among individuals living in more deprived
areas, but the extent of the imbalance varies by type of disease and sex. Most of the variation in health care utilization was
explained by morbidity burden. However, even after accounting for differences in morbidity, pro-poor horizontal inequity
was present in specialized outpatient care, emergency department, prescription, and primary health care costs and this fact
was more apparent in females than males; inpatient costs exhibited an equitable distribution in both sexes.
Conclusions: Analyses of comprehensive administrative clinical information at the individual level allow the socioeconomic
gradient in chronic diseases and health care provision to be measured to a level of detail not possible using other sources.
This frequently updated source of information can be exploited to monitor trends and evaluate the impact of policy
reforms.Background
The existence of a socioeconomic health gradient is one
of the main concerns of public sectors in the European
Union [1] and other parts of the world [2]. Despite this,
commonly, health information systems do not have reli-
able data to detect health inequalities and inequities in
health care, to assess changes in these over time and to
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charge (except for outpatient prescriptions, for which
there is copayment) to all residents. Each person has
an assigned general practitioner, who acts as a gate-
keeper to the rest of the system. Health care services at
all levels of care are predominantly public in most re-
gions, and most health professionals are employees
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the Basque Country, one of the autonomous regions lo-
cated in the north of Spain, this organization is called
Osakidetza (the Basque Health Service) and was cre-
ated in 1983.
Nevertheless, the existence of a National Health Ser-
vice covering all the population and almost free at the
point of use does not prevent there being social inequal-
ities in health within the system; indeed, these are
known to be present in the Basque Country [3] and in
Spain as a whole [4], as there are in the rest of the EU
[5]. Moreover, there is some evidence that differences in
income can lead to dissimilar access given the same level
of need [6] and most published studies show a pro-poor
inequality in GP utilization, that is, people in deprived
groups are more likely to contact primary care services
than those with a higher income, [7], while the better-off
are more likely to receive specialized care [8]. In relation
to this, high priority is given to the reduction in social
health inequalities in Spain and specifically in the Basque
Country, where existing Health Plans and the current
“Strategy for tackling the challenge of chronicity” explicitly
sets this as a goal [9].
The focus of the aforementioned strategy is a new
framework, in which the phenomenon of chronicity is
considered central, due to the implications of chronic
health conditions and multimorbidity for both patients,
their families and caregivers, and health systems and
societies [10]. Under the strategy, a risk stratification
project was launched consisting of the building of a
huge dataset that links all the clinical and administrative
information available (in the domain of the public
health administration) for each resident in the Basque
Country.
The aim of this study is to exploit this dataset to
measure inequalities and inequities in health and health
care delivery for the entire population living in the
Basque Country. The richness of this dataset and its sys-
temic scope is one of the strengths of this study, because
it overcomes the limitations of most survey-based re-
search and other studies using databases that do not
provide a comprehensive picture of prevalence and ex-
penditures across a health system, being limited to cer-
tain age groups, diseases or record systems (e.g., only
those for primary care).
Our aims are i) to estimate, from data in clinical and
administrative records from the Basque Health Service,
the prevalence of chronic diseases in the population, ii)
to measure the level of socioeconomic-related inequal-
ity in these prevalences, and iii) to investigate the ex-
tent and direction of inequities in health care provision
with respect to socioeconomic deprivation in the
Basque Country. Finally, we analyze the implications of
our findings for health policies in aged societies.Methods
Ethics statement: This study is a part of a project that
was approved by the Ethics Committee of the Basque
Country. We used databases that employ an opaque
identifier to ensure patient confidentiality.Data
This study utilized the database prepared by the popu-
lation stratification program (PREST) of the Basque
Health Service. This program was launched in 2010 with
the aim of classifying all citizens of the autonomous re-
gion in terms of their future care needs. To this end,
data recorded since 2007 were collected from various
sources, for the following variables: diagnoses (primary
care, emergency department, and inpatient), prescrip-
tions, procedures and costs of care. A more detailed de-
scription is available elsewhere [11].
The study population included every individual who
on 31st August 2011 was covered by public health insur-
ance in the Basque Country and who had been covered
for at least 6 months in the previous year, regardless of
whether or not they had used or had any contact with
the Basque Health Service.
The Spanish National Health System provides almost
universal (99.5%) coverage to Spanish citizens and for-
eign nationals within the Spanish national territory [12].
Only 0.5% of the population falls outside this welfare
network, this group consisting of high-income non-
salaried individuals who are not obliged to join the social
security system [13]. Individuals are included in the
PREST database as a function of their insurance status
and it is not a requirement that they first make contact
with the health services; that is, we observed almost all
the inhabitants of the Basque Country.
The database includes individual-level information on
age, sex, health care utilization by type of service and
diagnosis, Adjusted Clinical Group (ACG) categories, a
small area of residence indicator based on census tracts,
and the general practice at which they are registered.Chronic diseases
We analyzed a comprehensive list of chronic diseases as
well as the presence of multimorbidity. In the Basque
Health Service, in accordance with the policy of the
Ministry of Health, Social Services and Equality of Spain,
diagnoses on hospital discharge forms, emergency de-
partment databases and primary care medical records
are coded according to ICD-9-CM [14], while the ATC
[15] coding system is used for drugs prescribed by pri-
mary care doctors. With this information, residents in
the Basque Country are classified annually using ACGs
[16], a case-mix system that enables health problems to be
identified from diagnoses and prescriptions, as well as to
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according to their health care needs and its costs.
In the present study, we analyzed a four-year period of
data for each of the patients. For this, we adapted a
methodology previously applied in the literature [17]: we
developed a list of 52 diseases and defined specific cri-
teria for each one to consider it active. A description of
this process is included as Additional file 1. The pres-
ence of diseases was determined using all available infor-
mation in the databases of the Basque Health Service for
the four-year period, though patients within the database
who were followed-up for less than full four years were
also included. This yielded to a total of 2,262,698 indi-
viduals, of whom 1,832,086 had an uninterrupted record
from 1st September 2007 onwards. Out of the remaining
individuals, 95,714 had shorter follow-up periods be-
cause they were born after September 2007 or for other
reasons, such as, moving house, changes in type of in-
surance or administrative factors.
Multimorbidity was defined, for the purposes of this
study, as the coexistence of more than one health prob-
lem in the same patient considering the 52 conditions
under study.
Health care provision
We measured health care provision in terms of cost-
weighted utilization of health care. Health care use was
estimated for a 12-month period (from 1st September
2010 to 31st August 2011). We consider separately the
cost of the following types of services: primary care (in-
cluding visits to physicians and nurses, laboratory test
and radiology examinations), specialized outpatient care
(visits to specialists, rehabilitation, dialysis, radiotherapy
and chemotherapy services), inpatient stays, emergency
department attendances, and prescribing.
In the case of prescribing, the cost was calculated dir-
ectly from primary care prescriptions recorded in the
electronic health records. For the other types of use, the
number of services for each patient was multiplied by a
standardized cost. The costs of hospitalization and out-
patient surgery were calculated in relation to their
weight in the corresponding Diagnosis-Related Groups
(DRGs). Information on some services was not available
and these were therefore excluded from the analysis: ad-
mission to psychiatric hospitals, home hospitalization
and day care services (except the procedures and ser-
vices listed above), health care transport, prostheses and
other equipment provided to patients at home.
Socioeconomic measure
The deprivation index of the census tract (median popu-
lation size = 1,200 inhabitants) of residence proposed by
the MEDEA project [18] was used as a proxy for
individual socioeconomic position. Five indicators wereincluded in this index (baseline year 2001) based on:
rates of unemployment; low educational attainment,
overall and among young people (16–29 years); manual
workers; and temporary workers.
Inequality measures
We use a concentration index (CI) as our measure of
socioeconomic-related inequality [19]. CIs are bivariate
measures of inequality, measuring inequality in one vari-
able (in our case health status and health care costs) re-
lated to the ranking of another variable (in our case area
deprivation). Following Wagstaff, 2002 [20] the formula
for the CI of socioeconomic inequality can be written as
follows:






where n is the sample size; hi is the health/health care
measure; μ is the average health/health care measure;
and Ri ¼ in is the fractional rank in the socioeconomic
distribution of the ith person, where i =1 for the poorest
and i = n for the richest. The CI takes a positive (nega-
tive) value when there is socioeconomic-related inequal-
ity favoring the rich (poor).
One of the main advantages of CIs is that they make it
possible to summarize the extent of inequality in a single
measure that can be used to compare inequality levels
across time, areas or, as in our case, disease groups and
types of services.
A problem with CIs of binary variables is that they are
mean dependent [21]. To account for the binary nature
of the health indicators used in this study, we apply the
normalization proposed by Wagstaff, 2005. This allows
us to compare the levels of inequality in the burden of
the different diseases with varying levels of prevalence.
We report the level of socioeconomic inequality for each
chronic disease and multimorbidity category, separately
for males and females and after standardizing by age.
With respect to the analysis of health care costs, socio-
economic inequalities in health care simply reflect that
different individuals receive different amounts of care,
but they tell us very little about potential inequity as
they do not take into account differences in needs be-
tween individuals [22]. For instance, finding that poorer
individuals consume proportionally more health care
would not be interpreted as inequity. Therefore, in order
to measure inequity, we need to standardize by the dif-
ferent levels of needs across individuals. To do so, we
measured horizontal inequity as the difference between
the CI of actual health care costs and the CI of need-
predicted health care costs [23]. Need-predicted health
care costs were derived from the predicted values of an
ordinary least-squares regression model of actual health
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dicators (while we did not want to standardize for the
non-need-related variables, omitting them from the
regression would have biased the coefficients of the
need-related variables [24]). The effects of the non-need
-related variables in the prediction were neutralized by
setting them equal to their mean values.
We utilized the variables available in our dataset as
need and non-need indicators. Classifying variables as
need or non-need variables requires making value judg-
ments about which factors ought to affect use and which
factors ought not to. Empirical analyses of equity in
health service use have commonly classified socioeco-
nomic variables as non-need indicators, and the com-
mon practice involves using data on age, gender and
morbidity indicators as need measures. We follow this
convention in this study. The indicators of need in our
models included: sex, age (in this case specified as
whether or not the individual is 65 years old or older in
order to measure the effect of being elderly on health
care cost) and Adjusted Diagnosis Groups (ADGs),
which are a component of the ACG case-mix system.
ADGs are 32 categories, specifically designed to aggre-
gate diagnoses into groups with similar severity, duration
of condition, and needs for health care treatment [16].
We used the deprivation index as a non-need-related in-
dicator in the regression models. One of the useful fea-
tures of CIs is that it is possible to measure the
contribution of different factors (covariates in the regres-
sion model) to the inequality indices [25]. We exploit
this property and measure separately the contribution of
each of the need- and non-need-related factors to the
level of observed socioeconomic-inequality in health
care costs.
All CIs were adjusted for clustering at level of the gen-
eral practice where the individual was registered.
Results
Summary statistics
The total population was 2,262,686, of which 50.90% were
female. The proportion of children (age <18 years) was
15%, and 20% of individuals were over 65. Table 1 shows
the distribution of the population by age group and sex,
and the prevalence of the 52 chronic conditions consid-
ered in this study. Hypertension was the most common
condition, present in 19% of the population, followed by
anxiety/stress disorders which were more prevalent among
females than males (14% vs. 7%, respectively). Diabetes,
degenerative joint disease, dyspepsia, malignancies, low
back pain and asthma were among the most common
conditions in both sexes. On the other hand, hypo-
thyroidism, osteoporosis and depression were more highly
prevalent among females, while the prevalence of chronic
obstructive pulmonary disease (COPD), ischemic heartdisease, and other chronic heart diseases were consider-
ably higher in males.
The average number of chronic diseases per person
was 0.97 and the percentage of the population with two
or more of such diseases was 23.61%.
Inequalities in health
Figure 1 presents the main results with respect to the
extent of age-adjusted socioeconomic inequalities in
each disease area for males and females. For the vast
majority of health conditions, the CIs were found to be
negative indicating that the burden of disease is dispro-
portionally concentrated among individuals living in
more deprived areas. Interestingly, the steepness of the
socioeconomic gradient in the prevalence of diseases
varied substantially between diseases, especially among
females. HIV, alcohol and drug problems were the health
conditions in which we found the greatest socioeco-
nomic inequality among males, while HIV, diabetes and
low back pain were the conditions for which inequalities
were most pronounced among females. For three differ-
ent diseases for each sex the concentration index was
positive, suggesting that the pathology was dispropor-
tionally more prevalent among individuals living in
richer areas. These were: atrial fibrillation, Parkinson’s
and diverticular disease of the intestine for males (the
difference for the last of these being statistically signifi-
cant); and malignancies, bronchiectasis and osteoporosis
for females (differences for the last two statistically sig-
nificant). For most conditions, the extent of inequality
was larger for women than it was for men, with the ex-
ception of a few diseases where the gap was notably
large: the level of inequality in alcohol problems, COPD,
anorexia, and bronchiectasis was much larger among
males than females.
Figure 2 shows the level of socioeconomic inequality
in multimorbidity by sex. The results indicate that, after
controlling for age, individuals living in more deprived
areas had disproportionally more comorbidities than
those living in less deprived areas. The extent of inequal-
ity observed increased when we defined multimorbidity
by the presence of an increasingly larger number of dis-
eases. In every case, there was greater inequality among
females than males.
Inequity in health care provision
Table 2 lists the CIs of observed and need-predicted
costs, together with the estimates of horizontal inequity
in total health care costs and disaggregated into primary
care, specialized outpatient care, emergency department
attendances, prescribing and inpatient stays.
CIs of observed health care are negative in every case,
suggesting that health care provision was disproportion-
ally concentrated among those living in poorer areas for
Orueta et al. BMC Public Health 2013, 13:870 Page 5 of 11
http://www.biomedcentral.com/1471-2458/13/870every type of use. After accounting for the differences in
the levels of need, the indices of horizontal inequity contin-
ued to be pro-poor in most cases, although the magnitude
of the indices decreased dramatically and in some cases be-
come non-significant. The values of the indices of horizon-
tal inequity also indicated that the pro-poor bias is greater
for specialized outpatient care and emergency departmentTable 1 Age profile and prevalence of chronic diseases in the
MALE FEMALE
Total sample 1,111,047 49.10% 1,151,639 50.90% R
a
t
By age groups G
0-17 175,435 15.80% 164,105 14.26% C
I
18-44 429,365 38.65% 407,960 35.43% H
45-64 313,689 28.23% 319,435 27.74% D
65-74 98,916 8.90% 110,762 9.62% C
75+ 93,642 8.43% 149,377 12.98% S
o
P
Prevalence of chronic disease V
Hypertension 207,478 18.67% 223,753 19.43% P
Anxiety & other neurotic, stress
related & somatoform
disorders
80,755 7.27% 161,981 14.07% I
Diabetes Mellitus 70,614 6.36% 60,412 5.25% A
Degenerative joint disease 25,897 2.33% 60,878 5.29% E
Treated dyspepsia 33,624 3.03% 53,088 4.61% I
Depression 19,944 1.80% 59,894 5.20% P
Hypothyroidism 11,125 1.00% 67,968 5.90% T
Malignancies 35,543 3.20% 34,429 2.99% D
Low back pain 23,777 2.14% 41,352 3.59% M
Asthma (currently treated) 30,161 2.71% 33,709 2.93% D
Glaucoma 24,827 2.23% 33,274 2.89% C
Osteoporosis 3,019 0.27% 53,283 4.63% H
Atrial fibrillation 27,818 2.50% 22,860 1.98% P
Emphysema, chronic bronchitis,
COPD
33,653 3.03% 16,643 1.45% B
Peripheral neuropathy, neuritis 15,561 1.40% 32,028 2.78% O
m
Ischemic heart disease 32,402 2.92% 13,680 1.19% A
Chronic heart disease, others 26,611 2.40% 18,637 1.62% H
Cerebro-vascular disease 22,682 2.04% 22,268 1.93% T
Prostatic hypertrophy 43,403 3.91% — — M
Deafness, hearing loss 20,264 1.82% 20,518 1.78% A
Dementia 12,308 1.11% 25,141 2.18%
Blindness & low vision 13,864 1.25% 17,118 1.49% M
Chronic kidney disease 13,449 1.21% 12,242 1.06%attendance, while the indices were lower for primary care
and prescriptions. Among males, inpatient stays appeared
to be disproportionally concentrated among richer individ-
uals after accounting for needs, although the horizontal in-
equity estimate is very small and non-significant. Similar to
analysis of inequalities in chronic diseases, we found in-





8,571 0.77% 14,858 1.29%
out 19,072 1.72% 3,719 0.32%
hromosomal anomalies or
nherited metabolic disorders
12,765 1.15% 9,527 0.83%
eart failure 10,151 0.91% 11,057 0.96%
iverticular disease of intestine 8,221 0.74% 11,120 0.97%
hronic liver or pancreatic disease 11,942 1.07% 6,358 0.55%
chizophrenia, affective psychosis
r bipolar disorder
8,068 0.73% 7,073 0.61%
arkinson’s disease 5,743 0.52% 6,838 0.59%
iral Hepatitis 7,083 0.64% 4,510 0.39%
aralysis or muscular dystrophy 5,941 0.53% 5,208 0.45%
rritable bowel syndrome 3,298 0.30% 6,298 0.55%
lcohol problems 7,037 0.63% 1,887 0.16%
pilepsy (currently treated) 4,729 0.43% 4,162 0.36%
nflammatory bowel disease 4,381 0.39% 4,314 0.37%
eripheral vascular disease 6,675 0.60% 1,698 0.15%
reated constipation 2,484 0.22% 4,729 0.41%
isorders of the immune system 2,754 0.25% 3,980 0.35%
igraine 1,055 0.09% 5,120 0.44%
evelopmental disorder 3,750 0.34% 2,272 0.20%
hronic sinusitis 2,518 0.23% 3,369 0.29%
ematologic chronic disorders 2,598 0.23% 3,140 0.27%
soriasis or eczema 2,944 0.26% 2,060 0.18%
ronchiectasis 2,137 0.19% 2,863 0.25%
ther psycho-active substance
isuse
3,791 0.34% 855 0.07%
ttention deficit disorder 2,555 0.23% 844 0.07%
IV, AIDS 1,796 0.16% 839 0.07%
ransplant status 1,364 0.12% 764 0.07%
ultiple sclerosis 628 0.06% 1,308 0.11%
norexia or bulimia 109 0.01% 1,377 0.12%
ultimorbidity (2+ conditions) 235,617 21.21% 298,640 25.93%
Figure 1 Socioeconomic-related inequality in age-adjusted chronic diseases by sex.
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equalities in observed health care costs are summarized
in Figure 3 (note that an alternative and equivalent ap-
proach to measuring horizontal inequity is to subtract
the contribution of the need-related variables from the
inequality index of observed health care). Most of the
variation in health care costs was explained by ADG
categories. This was followed by the contribution of the
deprivation index which, for instance, explained 35% of
the pro-poor bias in specialized outpatient care. After
controlling for ADG category, the impact of whether
an individual was aged 65 or over was relatively small
for every type of health care, with the exception of pre-
scriptions where it explained 15 and 13% of the socio-
economic variation in prescription costs in females and
males, respectively. Unexplained socioeconomic vari-
ation, measured by the contribution of the residual
term, was in every case negligible.Discussion
The exploitation of administrative health databases in
the Basque Country has allowed us to describe the
prevalence of chronic diseases, level of multimorbidity
and use of health care resources in the entire population
and to analyze differences by socioeconomic deprivation
and sex. The prevalence of the great majority of the ob-
served chronic diseases is concentrated among the most
disadvantaged social groups who also have higher rates
of multimorbidity. These inequalities in morbidity bur-
den account for most of the differences found in use of
health resources and there is only a small degree of hori-
zontal inequity (difference between use of and need for
health care), in most cases this being pro-poor.
Analyzing chronic diseases individually, the largest in-
equalities are found in pathologies related to high-risk
behaviors, substance misuse (smoking, alcohol and other
substance abuse) and sedentary life-style, and to
Figure 2 Socioeconomic-related inequality in age-adjusted
multimorbidity by sex.
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However, the two sexes do not show analogous patterns
in all the conditions and, in general, greater differences
were observed in women than men.
Although the methodology used in this study is, in
several respects, different to that employed by other
authors, our results partially agree with studies in the lit-
erature. In a previous study on socioeconomic inequality
in the Basque Country, Esnaola et al. found that the
greatest differences in causes of mortality between socio-
economic groups were in overdoses of illegal drugs, cir-
rhosis, AIDS and COPD [3]. Further, a review of data
from surveys in eight European countries identified an
association between a lower level of education and a
higher prevalence of many types of chronic diseases
[26], while other research has demonstrated associations
between unfavorable socioeconomic conditions and, in
particular, cardiovascular disorders [27], diabetes, alco-
holism, mental illness, asthma and lumbago, amongTable 2 Socioeconomic-related inequity in health care costs
Observed CI
Female Male
Primary care −0.0655* −0.0480*
Specialized outpatient care −0.0764* −0.0676*
Emergency department attendances −0.0927* −0.0720*
Inpatient stays −0.0844* −0.0676*
Prescriptions −0.0662* −0.0417*
Total −0.0753* −0.0597*
Observed and need-predicted concentration indices (CIs) and estimates of horizont
* p < 0.05.others. It might seem surprising that, although we found
inequalities in the prevalence of stroke (especially in
women), these were not as large as the results published
by other authors [26]; however, this finding is consistent
with a comparative study of causes of mortality across
22 European countries, in which the Basque Country
was found to have the lowest levels of inequity associ-
ated with level of education for cardiovascular diseases
in general, and stroke in particular [28].
On the other hand, for some diseases our results differ
from previously published findings. One of the most
striking cases is that of skin conditions, which in our
study were relatively strongly concentrated in more de-
prived communities, while other authors have found no
relationship between poor socioeconomic conditions
and this type of health problem [27,29]. Nevertheless,
such an association has been established for certain der-
matological conditions [30], so that it seems reasonable
to suppose that an analysis separating dermatologic
problems into smaller and less heterogeneous groups
might have found various types of relationship between
social factors and these conditions.
It is well known that the inequalities between social
groups in many risk factors vary between the sexes in
magnitude and even direction. For example, there are
greater inequalities related to level of education for obesity
in women, and for smoking [28] and alcohol abuse [31] in
men. In relation to this, it seems logical to suppose that
social class plays a different role in each sex with regards
to the prevalence of specific chronic diseases. These facts
may explain, at least to a certain extent, the observed dif-
ferences in CIs between men and women. In particular, we
found that inequity in diabetes is much greater among
women, confirming the results of previous studies based
on data from surveys and mortality registries [3,26,27,32].
We also found inequity in the prevalence of multi-
morbidity and this was greater the larger the number of
diseases diagnosed in same person. In addition, in all
cases, the inequality was larger in women. Although for
many years it has been known that the number of people
with multiple apparently unconnected conditions is higherNeed-predicted CI Horizontal inequity
Female Male Female Male
−0.0483* −0.0391* −0.0172* −0.0090*
−0.0454* −0.0417* −0.0310* −0.0259*
−0.0664* −0.0552* −0.0263* −0.0168*
−0.0770* −0.0752* −0.0074 0.0077
−0.0462* −0.0361* −0.0200* −0.0056
−0.0569* −0.0533* −0.0184* −0.0065
al inequity in total health care costs.
Figure 3 Decomposition of socioeconomic-related inequity in
health care cost by type of service and by sex.
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studying multimorbidity, as well as its consequences for
patients, their families, health care organizations and soci-
ety in general, is a more recent phenomenon. In recent
years, numerous publications have confirmed the
relationship between poor socioeconomic status and
multimorbidity, using data from primary care medical re-
cords [17,34,35], surveys of the general population [36] or
users of certain types of health care services [37] and in-
terviews with doctors and patients [38]. Most of these
studies have been carried out in developed countries, but
there is also some evidence from low and middle-income
countries [39].
In the Basque Country, people with poor socioeco-
nomic status use more health resources, especially fe-
males. This inequality is mostly explained by the fact
that these deprived groups have greater health care
needs given their greater morbidity burden. Neverthe-
less, we still detected a certain degree of pro-poor in-
equity in the case of specialized outpatient care and
emergency services, and to a lesser extent also in pri-
mary care and prescriptions, while no inequity was
detected in inpatient care. These results are not in agree-
ment with those of other studies that used surveys
[8,40-42] or administrative databases [43] as a source of
information. These other studies have repeatedly found
a pro-rich bias regarding specialized outpatient care, in
many different countries in Europe and in the USA. As
for primary care, the findings are not so consistent, the
direction of the inequity (pro-rich or pro-poor) varying
between countries; nevertheless, in general, thedifferences are smaller and the use of primary care
seems to be more related to need than economic factors.
One factor that may partly explain the different use of
specialized care observed in our data is that some of the
Spanish population, in general those with higher in-
comes, is covered by private medical insurance as well
as the Public Health System [44,45]. Specifically, in
2011, 17.6% of the population of the Basque Country
were exclusively covered by private health insurance or
had private cover in addition to the public provision
[46]. People who are doubly insured often go to private
specialized care clinics, in order to avoid the waiting lists
for appointments in the Public Health Service. In any
case, a previous study carried out in Spain, that included
people who have only public health insurance, found pro-
rich inequity [47] and, in another one analyzing separately
the utilization of public and private health care services,
there appeared to be an equitable use of public specialized
care, and certainly no pro-poor tendency [48].
Our study has the following strengths. First, it includes
almost the entire population of the geographical area
studied, thus avoiding selection bias. Second, it exploits
a database containing information from primary, special-
ized outpatient and inpatient care, as well as prescrip-
tions; as other authors have established, the use of a
single source can produce inaccurate estimates [49,50],
while the complementary use of various sources contrib-
utes to a better description of people’s health problems
[51]. Furthermore, by cross-checking data on prescrip-
tions and diagnoses it is possible to differentiate between
active and non-active chronic diseases and, to achieve
this, we adapted a methodology that has already been
used by other authors [17]. Thirdly, thanks to this com-
prehensive data set, our study describes a wide range of
specific diseases rather than being limited to self-report
general health indicators (which is often the case in
survey-based research). It also includes pathologies that
are the cause of considerable suffering and disability but
not fatal, and so are not considered in studies analyzing
only mortality data. Finally, in order to control for morbid-
ity and estimate health care needs we opted to employ the
ACG case-mix system, a well-known instrument, the use-
fulness of which has been confirmed in various different
countries.
Our study also has certain limitations. Firstly, adminis-
trative databases only contain information about prob-
lems for which people seek medical attention. Therefore,
the prevalence of diseases can only reflect known cases
and excludes the presence of diseases that are present
but not known of by the patients or their doctors. The
distribution of undiagnosed cases might be influenced
by factors including accessibility to health care services
and help seeking behavior of patients. Secondly, our
database contains information from primary and
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admissions, but not psychiatric hospitals; even though
patients admitted in such hospitals are also usually cared
for by primary care doctors, given their special charac-
teristics, it is feasible that their health records were not
as complete as for the rest of the population. Moreover,
as previously noted, we do not have access to informa-
tion from the health services in the private sector as they
are not under the management of the Basque Health
Service. As a consequence, in this research we were not
able to explore the effect of the existence of double in-
surance. Thirdly, regarding the cost of care per patient,
our health service has no direct data and, hence, costs
were calculated from the standard pricing of the services
provided and in some specific cases the costs were not
available (mainly admissions to mental health hospitals,
home hospitalization and some components of day care
services). Finally, being based on socioeconomic indica-
tors at the level of area of residence, our study has the
limitations common to ecological studies. Although
there is known to be a relationship between socioeco-
nomic deprivation and poor health, the contributions of
individual and context-related factors have not been
clearly established. In any case, the area-based measures,
reflecting community-wide characteristics, turn out to
be indicators with their own characteristics and do not
behave solely as proxy measures for individual socioeco-
nomic variables [52]. The deprivation index employed in
this study is a compound index, built from five indica-
tors corresponding to rates of employment and educa-
tional attainment [18]. In their first models, the
developers of this index included a further nine variables
related to housing, sociodemographic characteristics
(single parent households, old age, immigrants from
low-income countries and recently arrived immigrants)
and environmental factors (pollution, noise levels, delin-
quency). On the basis of the results of multivariate ana-
lysis, however, they decided not to include these
variables, and to construct the index using the five afore-
mentioned indicators which saturated in the first dimen-
sion by the identification of a single factor structure
applying principal component analysis. In any case, the
information in this index could be insufficiently exhaust-
ive to reflect all the factors of interest.
Although the relationship between low socioeconomic
status and poorer health status is complex, and the under-
lying mechanisms have not been clearly established, the
existence of health inequalities is well recognized. Most
people in the world aspire to greater solidarity in the field
of health and wish their governments to introduce policies
that guarantee health protection and promote equity [53].
To face this challenge, it is necessary to develop a broad
range of interventions and, as stated by the WHO Com-
mission on Social Determinants of Health [2], we need todevelop instruments that measure the magnitude of the
problem, facilitate its analysis, and evaluate the effects of
said interventions. We need new indicators, different from
those currently employed, which only provide average
values of health of the general population as a whole [54].
In relation to this, research such as the present study,
based on the use of administrative health databases, pro-
vides useful information to quantify inequalities and in-
equities in health and health care provision [55] and, given
the accessibility and constant updating of such databases,
this approach may help to monitor changes in these in-
equalities and inequities over time.Conclusions
Commonly, health information systems do not have reli-
able data to detect health inequalities and inequities in
health care, to assess changes in these over time and to
monitor the impact of related policies. Exploiting a huge
dataset that links all the clinical and administrative in-
formation available (in the domain of the public health
administration) for each resident in the Basque Country,
we observed the prevalence of 52 chronic conditions,
quantified individual health care costs and estimated the
extent and direction of inequality with respect to socio-
economic deprivation. Analyses of comprehensive ad-
ministrative clinical information at the individual level
allow the socioeconomic gradient in chronic diseases
and health care provision to be measured to a level of
detail not possible using other sources.Additional file
Additional file 1: Definition of chronic conditions.
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